TITLE

Anti-VEGF best option for managing macular edema caused by CRVO

AUTHOR(S)
Boyle, Erin L.; Harcharek, Alexandra; Hasson, Matt; Hsvidas, Cara; Nale, Patricia; Master, Joseph; Pagnani, Michelle; Preston, Courtney
PUB. DATE
February 2011
SOURCE
Ocular Surgery News;2/25/2011, Vol. 29 Issue 4, p25
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers the insights of doctor Neil M. Bressler regarding the efficacy of monthly intravitreal injection of ranibizumab in treating macular edema caused by central retinal vein occlusion (CRVO).
ACCESSION #
86439056

 

Related Articles

  • Anti-VEGF improves visual acuity in eyes with macular edema due to retinal vein occlusion. Hasson, Matt; Pagnani, Michelle; Preston, Courtney // Ocular Surgery News;3/25/2011, Vol. 29 Issue 6, p34 

    The article reports on the prospective randomized study which reveals that anti-VEGF injection improves visual acruity in eyes with macular edema due to the occlusion of retinal vein.

  • New kid on the block. Krader, Cheryl Guttman; Korobelnik, Jean-Francois // Ophthalmology Times;3/1/2013, Vol. 38 Issue 5, p26 

    The article reports on a randomized, sham-controlled GALILEO study that was conducted in Europe and Asia to determine efficacy of anti-vascular endothelial growth factors (VEGF) agent in treating patients with CRVO-related macular edema. It mentions that the study involved patients with mean age...

  • Study supports anti-VEGF, laser for patients with diabetic macular edema. Boyle, Erin L.; Harcharek, Alexandra; Hasson, Matt; Hsvidas, Cara; Nale, Patricia; Master, Joseph; Pagnani, Michelle; Preston, Courtney // Ocular Surgery News;2/25/2011, Vol. 29 Issue 4, p24 

    The article reports that intravitreal ranibizumab with deferred or prompt focal/grid laser has resulted to superior to optical coherence tomography outcome and superior visual acuity than in focal/grid laser treatment alone in visually impaired patients according to doctor Neil M. Bressler.

  • Reading speed in patients with retinal vein occlusion improves after anti-VEGF treatment. DiPietro, Cheryl; Ying, Howard S. // Ocular Surgery News;7/25/2013, Vol. 31 Issue 14, p24 

    The article focuses on a findings of a study which revealed the improvement in reading speed of patients with retinal vein occlusion after undergoing anti-vascular endothelial growth factor (VEGF) treatment. It details the methodology of the study and the treatment procedure underwent by the...

  • NEWTON: Aflibercept injection for previously treated macular edema associated with central retinal vein occlusions. Khuran, Rahul; Olsen, Timothy W. // Ocular Surgery News;7/25/2013, Vol. 31 Issue 14, p27 

    The article focuses on a study which investigated the therapeutic use of intravitreal aflibercept injection for treatment of macular edema following central retinal vein occlusion. It details the methodology of the study authored ophthalmologists from Northern California Retina Vitreous...

  • SCORE2 to compare aflibercept, bevacizumab for treating CRVO. Hasson, Matt // Ocular Surgery News;7/25/2014, Vol. 32 Issue 14, p22 

    The article offers information on a study on comparison between aflibercept and bevacizuma for treating macular edema associated with central retinal vein occlusion as of July 2014. The topics discussed include treatments approved by the U.S. Food and Drug Administration for CRVO, and assessment...

  • SD-OCT helps predict response to VEGF therapy in patients with RVO. Nale, Patricia; Swartz, Shauna // Ocular Surgery News;9/25/2014, Vol. 32 Issue 18, p24 

    The article focuses on a study presented at the 2014 American Society of Retina Specialists (ASRS) annual meeting in San Diego, California which found that spectral-domain optical coherence tomography can help predict the response of retinal vein occlusion (RVO) patients to vascular endothelial...

  • Anti-VEGF patterns of use may vary for DME cases in clinical practice. Harrison, Laird // Ophthalmology Times;Sep2015, Vol. 40 Issue 15, p70 

    The article presents the results of a study on the effectiveness of anti-vascular endothelial growth factor (VEGF) treatments for diabetic macular edema conducted by Dr. Kevin Blinder at Washington University in St. Louis, Missouri. Topics mentioned include disappointing results in clinical...

  • Visual acuity gains maintained in VIBRANT. Nale, Patricia; Swartz, Shauna // Ocular Surgery News;9/25/2014, Vol. 32 Issue 18, p17 

    The article focuses on a study presented at the 2014 American Society of Retina Specialists (ASRS) annual meeting in San Diego, California which found that improved visual acuity in patients receiving intravitreal aflibercept injection than in those receiving laser treatment for branch retinal...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics